N

New Horizon Research Group | Medical Affiliated Research Center

Research site
(Unclaimed)
Location
303 Williams Avenue South West Suite 511, Huntsville, Alabama, United States of America
Site insights

Top conditions

Migraine Disorders (5 trials)

COVID-19 (4 trials)

Hypogonadism (4 trials)

Erectile Dysfunction (3 trials)

Human Influenza (3 trials)

Top treatments

Vonoprazan
Testosterone
Estradiol
Lansoprazole
ARD-0403
DA-8159
SPD476
Testosterone Undecanoate
Zonisamide
ONO-5129

Parent organization

This site is a part of New Horizon Research Group

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

6 of 42
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A New Sildenafil Oral Film in Patients With Erectile Dysfunction

This is a Phase III, prospective, interventional, multi-center, randomized, double-blind, flexible-dose, placebo-controlled, parallel group clinical...

Enrolling
Erectile Dysfunction
Drug: Sildenafil Oral Film 25 mg, 50 mg, 75 mg or 100 mg
Drug: Placebo

This is a randomized, double-blind, placebo-controlled, parallel-dosing, multi-center study to evaluate the efficacy and safety of Rencofilstat as ev...

Enrolling
Fibrosis, Liver
Nonalcoholic Steatohepatitis (NASH)
Drug: Placebo
Drug: Rencofilstat
Locations recently updated

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vaccine is compared to...

Enrolling
COVID-19
Influenza
Biological: Placebo
Biological: Influenza and COVID-19 Combination B

The purpose of this clinical protocol is to learn about the safety, tolerability, and immunogenicity of new BNT162b2 RNA-based vaccine candidates tar...

Active, not recruiting
COVID-19
SARS-CoV-2 Infection
Biological: BNT162b2 (Omi XBB.1.5)

This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenz...

Active, not recruiting
Seasonal Influenza
Biological: Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine
Biological: mRNA-1010

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting
Lower Respiratory Tract Illness
Biological: Placebo
Biological: RSVpreF

Trial sponsors

Pfizer logo

Pfizer (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems